Patents by Inventor Birgit Wasser

Birgit Wasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7883896
    Abstract: The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: February 8, 2011
    Assignee: MTM Laboratories, AG
    Inventors: Johannes Coy, Rainer Hipfel, Birgit Wasser
  • Publication number: 20090098544
    Abstract: The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.
    Type: Application
    Filed: March 17, 2008
    Publication date: April 16, 2009
    Inventors: Johannes Coy, Rainer Hipefel, Birgit Wasser
  • Patent number: 7355025
    Abstract: The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: April 8, 2008
    Assignee: MTM Laboratories, AG
    Inventors: Johannes Coy, Rainer Hipfel, Birgit Wasser
  • Publication number: 20050176930
    Abstract: The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.
    Type: Application
    Filed: May 16, 2003
    Publication date: August 11, 2005
    Inventors: Johannes Coy, Rainer Hipfel, Birgit Wasser